Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
19.28
-0.53 (-2.68%)
At close: Mar 28, 2025, 4:00 PM
19.32
+0.04 (0.23%)
After-hours: Mar 28, 2025, 6:50 PM EDT

Company Description

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

The company’s flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system.

It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user’s body.

In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data.

It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems.

The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008.

Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Tandem Diabetes Care, Inc.
Tandem Diabetes Care logo
Country United States
Founded 2006
IPO Date Nov 14, 2013
Industry Medical Devices
Sector Healthcare
Employees 2,650
CEO John Sheridan

Contact Details

Address:
12400 High Bluff Drive
San Diego, California 92130
United States
Phone 858 366 6900
Website tandemdiabetes.com

Stock Details

Ticker Symbol TNDM
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001438133
CUSIP Number 875372203
ISIN Number US8753722037
Employer ID 20-4327508
SIC Code 3841

Key Executives

Name Position
John F. Sheridan President, Chief Executive Officer and Director
Leigh A. Vosseller Executive Vice President, Chief Financial Officer and Treasurer
Susan M. Morrison Executive Vice President and Chief Administrative Officer
Elizabeth Anne Gasser Executive Vice President and Chief Strategy and Product Officer
Mark Novara Executive Vice President and Chief Commercial Officer
Jean-Claude E. Kyrillos Executive Vice President and Chief Operating Officer
Rick A. Carpenter Chief Technical Officer
Shannon M. Hansen J.D. Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary
Tom Fox Chief Human Resources Officer
Dr. Jordan Pinsker M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Feb 26, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Nov 21, 2024 144 Filing
Nov 20, 2024 144 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 8, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 6, 2024 10-Q Quarterly Report
Nov 6, 2024 8-K Current Report
Oct 18, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 9, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals